EARLY

CANCER

DETECTION

What if we could reduce delay in detection?

Introducing, the HrC test

WHAT IS HrC?

Simple risk assessment test to facilitate early detection of cancer.

Through HrC we can: 

​

Confirm "no risk" of cancer presence (which also indicates no risk of developing cancer within the following one year)

Assess risk of cancer presence which can vary from negligible, low, moderate, to high.

WHAT DOES THE HrC TEST DETECT? 

Based on a proprietary blood processing protocol, we enrich a special class of pluripotent stem cells, including cancer stem cells, and use multiple highly-specific markers, including RNA, protein & molecular marker. These markers potentially show up in blood post cancer initiation, and nearly months before tumour formation. It is this property of stem cells to mobilise from an implicated organ and come into circulation that gives HrC this potential month window for early detection (Stage 0). 

​

HrC assesses risk of cancer presence with 93% accuracy/sensitivity*, and is stage agnostic. This compares very favourably with other standard liquid biopsy tests where accuracy increases with stage of cancer, from 16% @Stage I to over 90% @Stage IV. HrC facilitates early detection by tracking (not predicting) risk of cancer presence. This triggers diagnostic tests to be initiated close to tumour formation. 

KEY FEATURES OF HrC TEST

IDEAL FOR

(Smokers, Drinkers, Tobacco consumers, etc.) 

*In the indian population

CANCER AT A GLANCE

Globally, 50% of cases are detected at Stages III or IV

The unfortunate tragedy of diagnosis is the delay between formation of detectable tumour and its actual detection. 

Current diagnosis is through PET scans, and liquid biopsy, which can detect cancer only post formation of a detectable tumour. 

Most common types of

CANCER

globally

Peace of Mind Starts with Early Detection

REALITY OF CANCER DETECTION

Delay occurs because there is no alerting mechanism when a detectable tumour is formed, as symptoms show up much later. 

Screening

Detection

Initiation
(Tumerogenesis)

Detectable Tumour

Delay in Detection

UNDERSTANDING THE HrC SCORE

HrC PROCESS FLOW

Early Detection. Lasting Peace of Mind.

Our Trusted Brands & Clinical Credentials

At The Leading Clinic at Royal Kingston (TLCARK) we're committed to the highest standards of safety, results, and professionalism. Our Kingston-based dermatology and aesthetics clinic uses only the most advanced clinically proven technologies and premium aesthetics brands to deliver expert-led treatments in a safe environment. We proudly display our insurance, affiliations, and trusted suppliers as a reflection of our dedication to medical integrity, patient confidence, and outstanding care in our Kingston upon Thames clinic.

Contact Us

Site Links

Address

​

Unit 1, Baring House

1A Manorgate Road

Kingston upon Thames

KT2 7AW​

© 2026 The Leading Clinic at Royal Kingston Ltd. All Rights Reserved.
Company Registered in England and Wales with Company No: